Top Ten 2023: Drug Pricing and the Shift to Non-Institutional Care Settings
Episode 31 min 54s

Top Ten 2023: Drug Pricing and the Shift to Non-Institutional Care Settings

Based on AHLA’s annual Health Law Connections article, this special series brings together thought leaders from across the health law field to discuss the top ten issues of 2023. In the eighth episode, Jane Jerzak, Principal, PYA, speaks with Todd Nova, Attorney, Hall Render Killian Heath & Lyman PC, about key developments related to drug pricing and regulation of the pharmaceutical delivery system. They discuss the effects of recent changes to the 340B program, the impacts of American Ho...

You May Also Like

Community discussion